BUPRENORPHINE Side Effects

6955320-3 | Product Substitution Issue
on Aug 26, 2010 Male patient from UNITED STATES , weighting 121.0 lb, was treated with Buprenorphine (View Usage). Patient experienced the following unwanted or unexpected effects: product substitution issue. Buprenorphine dosage: 8mg Qd Sl.

6877080-7 | Hypotension, Rib Fracture, Syncope
Patient was taking Buprenorphine (View Usage). Patient had the following side effects: hypotension, rib fracture, syncope on Jul 27, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, weighting 152.0 lb, . Buprenorphine dosage: 1 Mg -tapered From 8 Mg- Daily Sl. Patient was hospitalized.

6860916-3 | Amnesia, Loss Of Consciousness
Adverse event was reported on Jul 07, 2010 by a Male patient taking Buprenorphine (View Usage) (Dosage: ) . Location: UNITED STATES , 44 years of age, After Buprenorphine was administered, patient had the following side effects: amnesia, loss of consciousness. During the same period patient was treated with KLONOPIN (View Klonopin Review and Klonopin Label ).

6846128-8 | Alpha 1 Foetoprotein Abnormal, Chills, Cold Sweat, Pregnancy, Vomiting In Pregnancy
on Jun 29, 2010 Female patient from UNITED STATES , 33 years of age, was treated with Buprenorphine (View Usage). Patient experienced the following unwanted or unexpected effects: alpha 1 foetoprotein abnormal, chills, cold sweat, pregnancy (What is pregnancy?), vomiting in pregnancy. Buprenorphine dosage: . During the same period patient was treated with SUBUTEX (View Subutex Review and Subutex Label ).


6786240-5 | Diplopia, Dysarthria, Nausea
on Jun 17, 2010 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with back pain (What is back pain?), parkinson's disease (What is parkinson's disease?), sleep disorder (What is sleep disorder?), depression (What is depression?) and was treated with Buprenorphine (View Usage). Patient had the following side effects: diplopia, dysarthria, nausea (What is nausea?). Buprenorphine dosage: 25 Mcg; Qh. During the same period patient was treated with ROTIGOTINE (View Rotigotine Review and Rotigotine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SELEGILINE (View Selegiline Review and Selegiline Label ), SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ).

6636964-5 | Unevaluable Event
Patient was taking Buprenorphine (View Usage). After Buprenorphine was administered, patient had the following side effects: unevaluable event on Sep 29, 2009 from UNITED STATES Additional patient health information: Female patient , 29 years of age, was diagnosed with substance abuse and. Buprenorphine dosage: .

6627755-X | Accident
Adverse event was reported on Jun 07, 2009 by a Male patient taking Buprenorphine (View Usage) (Dosage: ) . Location: UNITED STATES , 41 years of age, Patient experienced the following unwanted or unexpected effects: accident. During the same period patient was treated with COCAINE (View Cocaine Review and Cocaine Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), PROZAC (View Prozac Review and Prozac Label ), LAMICTAL CD (View Lamictal Cd Review and Lamictal Cd Label ), AFRIN (View Afrin Review and Afrin Label ).

6603689-1 | Abortion Induced, Foetal Growth Retardation, Multiple Congenital Abnormalities
on Feb 19, 2010 Female patient from FRANCE , 22 years of age, was treated with Buprenorphine (View Usage). Patient had the following side effects: abortion induced, foetal growth retardation, multiple congenital abnormalities. Buprenorphine dosage: .

6555145-7 | Embolic Stroke, Loss Of Consciousness
on Jan 13, 2010 Male patient from , 28 years of age, was treated with Buprenorphine (View Usage). After Buprenorphine was administered, patient had the following side effects: embolic stroke, loss of consciousness. Buprenorphine dosage: . Patient was hospitalized.

6399833-4 | Depressive Symptom, Suicide Attempt
Patient was taking Buprenorphine (View Usage). Patient experienced the following unwanted or unexpected effects: depressive symptom, suicide attempt on Sep 16, 2009 from GERMANY Additional patient health information: Female patient , 23 years of age, was diagnosed with pain (What is pain?) and. Buprenorphine dosage: 35 Mcg, Q1h. During the same period patient was treated with MORPHINE SULFATE (10 Mg, Unk) (View Morphine Sulfate Review and Morphine Sulfate Label ), ANTIDEPRESSANTS (View Antidepressants Review and Antidepressants Label ).

6396707-X | Depressive Symptom, Suicide Attempt
Adverse event was reported on Sep 16, 2009 by a Female patient taking Buprenorphine (View Usage) (Dosage: 35 Mcg, Q1h) was diagnosed with pain (What is pain?) and. Location: GERMANY , 23 years of age, Patient had the following side effects: depressive symptom, suicide attempt. During the same period patient was treated with MORPHINE SULFATE (10 Mg, Unk) (View Morphine Sulfate Review and Morphine Sulfate Label ), ANTIDEPRESSANTS (View Antidepressants Review and Antidepressants Label ).

4881382-3 | Abdominal Pain, Constipation, Diarrhoea, Faecaloma, Proctalgia
on Jan 09, 2006 Male patient from FRANCE , 96 years of age, weighting 176.4 lb, was diagnosed with proctalgia and was treated with Buprenorphine (View Usage). After Buprenorphine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), diarrhoea, faecaloma, proctalgia. Buprenorphine dosage: . During the same period patient was treated with CODOLIPRANE (View Codoliprane Review and Codoliprane Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), ALDACTAZINE (1/2 A Tablet - Qd) (View Aldactazine Review and Aldactazine Label ), TRIMETAZIDINE HYDROCHLORIDE (View Trimetazidine Hydrochloride Review and Trimetazidine Hydrochloride Label ), MEDICINALPRODUCT NOT SPECIFIED BY SENDER (Extend Release) (View Medicinalproduct Not Specified By Sender Review and Medicinalproduct Not Specified By Sender Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ACETYLSALICYLATE LYSINE (View Acetylsalicylate Lysine Review and Acetylsalicylate Lysine Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.

4844536-8 | Deafness, Incontinence, Micturition Disorder, Skin Exfoliation, Urethral Discharge
on Nov 22, 2005 Female patient from UNITED KINGDOM , 70 years of age, was diagnosed with pain (What is pain?) and was treated with Buprenorphine (View Usage). Patient experienced the following unwanted or unexpected effects: deafness, incontinence, micturition disorder, skin exfoliation, urethral discharge. Buprenorphine dosage: . During the same period patient was treated with MEDICINALPRODUCT NOT SPECIFIED BY SENDER (View Medicinalproduct Not Specified By Sender Review and Medicinalproduct Not Specified By Sender Label ).

4781124-6 | Intervertebral Discitis
Patient was taking Buprenorphine (View Usage). Patient had the following side effects: intervertebral discitis on Sep 13, 2005 from FRANCE Additional patient health information: Male patient , 37 years of age, . Buprenorphine dosage: . Patient was hospitalized.

4774139-5 | Arthritis, Meningitis, Psoas Abscess
Adverse event was reported on Sep 13, 2005 by a Male patient taking Buprenorphine (View Usage) (Dosage: ) . Location: FRANCE , 23 years of age, After Buprenorphine was administered, patient had the following side effects: arthritis (What is arthritis?), meningitis (What is meningitis?), psoas abscess. Patient was hospitalized.

4774136-X | Endocarditis
on Sep 13, 2005 Female patient from FRANCE , 31 years of age, was treated with Buprenorphine (View Usage). Patient experienced the following unwanted or unexpected effects: endocarditis (What is endocarditis?). Buprenorphine dosage: . Patient was hospitalized.

4774135-8 | Endocarditis
on Sep 13, 2005 Female patient from FRANCE , 25 years of age, was treated with Buprenorphine (View Usage). Patient had the following side effects: endocarditis (What is endocarditis?). Buprenorphine dosage: . Patient was hospitalized.

4774134-6 | Endocarditis, Tricuspid Valve Disease
Patient was taking Buprenorphine (View Usage). After Buprenorphine was administered, patient had the following side effects: endocarditis (What is endocarditis?), tricuspid valve disease on Sep 13, 2005 from FRANCE Additional patient health information: Female patient , 30 years of age, . Buprenorphine dosage: . Patient was hospitalized.

4774131-0 | Endocarditis
Adverse event was reported on Sep 13, 2005 by a Male patient taking Buprenorphine (View Usage) (Dosage: ) . Location: FRANCE , 31 years of age, Patient experienced the following unwanted or unexpected effects: endocarditis (What is endocarditis?). Patient was hospitalized.

4774130-9 | Endocarditis
on Sep 13, 2005 Male patient from FRANCE , 22 years of age, was treated with Buprenorphine (View Usage). Patient had the following side effects: endocarditis (What is endocarditis?). Buprenorphine dosage: . Patient was hospitalized.

4774128-0 | Abscess, Lymphangitis
on Sep 13, 2005 Male patient from FRANCE , 39 years of age, was treated with Buprenorphine (View Usage). After Buprenorphine was administered, patient had the following side effects: abscess (What is abscess?), lymphangitis. Buprenorphine dosage: . Patient was hospitalized.

4774126-7 | Abscess, Lymphangitis
Patient was taking Buprenorphine (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), lymphangitis on Sep 13, 2005 from FRANCE Additional patient health information: Male patient , 36 years of age, . Buprenorphine dosage: . Patient was hospitalized.

4774125-5 | Sacroiliitis, Sepsis
Adverse event was reported on Sep 13, 2005 by a Male patient taking Buprenorphine (View Usage) (Dosage: ) . Location: FRANCE , 39 years of age, Patient had the following side effects: sacroiliitis, sepsis (What is sepsis?). Patient was hospitalized.

4774124-3 | Candidiasis, Retinitis
on Sep 13, 2005 Male patient from FRANCE , 25 years of age, was treated with Buprenorphine (View Usage). After Buprenorphine was administered, patient had the following side effects: candidiasis, retinitis. Buprenorphine dosage: . Patient was hospitalized.

4704803-5 | Pulmonary Oedema
on Jun 28, 2005 Male patient from AUSTRALIA , 26 years of age, weighting 196.2 lb, was treated with Buprenorphine (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary oedema. Buprenorphine dosage: . During the same period patient was treated with METHYLENEDIOXYMETHAMPHETAMINE (Toxic Concentration : 2.4 Mg/l In Blood) (View Methylenedioxymethamphetamine Review and Methylenedioxymethamphetamine Label ), OLANZAPINE (Dose Unknwon) (View Olanzapine Review and Olanzapine Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), PSEUDOEPHEDRINE HCL (View Pseudoephedrine Hcl Review and Pseudoephedrine Hcl Label ), NALTREXONE (Dose Unknwon) (View Naltrexone Review and Naltrexone Label ).